{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T17:14:41Z","timestamp":1793812481632,"version":"4.6.1"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,14]],"date-time":"2025-08-14T00:00:00Z","timestamp":1755129600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,8,14]],"date-time":"2025-08-14T00:00:00Z","timestamp":1755129600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Medical Science and Technology Innovation Platform Support Project of Zhongnan Hospital, Wuhan University","award":["PTXM2020008"],"award-info":[{"award-number":["PTXM2020008"]}]},{"name":"Medical Science Advancement Program (Basic Medical Sciences) of Wuhan University","award":["TFJC2018004"],"award-info":[{"award-number":["TFJC2018004"]}]},{"name":"Non-profit Central Research Institute Fund of Chinese Academy of Medical Sciences","award":["2020-PT320-004"],"award-info":[{"award-number":["2020-PT320-004"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"DOI":"10.1186\/s12879-025-11395-3","type":"journal-article","created":{"date-parts":[[2025,8,14]],"date-time":"2025-08-14T18:38:43Z","timestamp":1755196723000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Low-level viremia and subsequent virologic failure among people living with HIV: a retrospective cohort study in China"],"prefix":"10.1186","volume":"25","author":[{"given":"Yuting","family":"Tan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wu","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Songjie","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dingyuan","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanmeng","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shi","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qianhui","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heng","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ke","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,14]]},"reference":[{"key":"11395_CR1","unstructured":"WHO Consolidated guidelines on the use of. antiretroviral drugs for treating and preventing HIV infection; Recommendations for a public health approach. Second edition. 2016. Available at:\u00a0http:\/\/www.who.int\/hiv\/pub\/arv\/arv-2016\/en\/. Accessed 16 Oct 2017."},{"key":"11395_CR2","unstructured":"Panel\u2003on\u2003Antiretroviral\u2003Guidelines\u2003for\u2003Adults\u2003and\u2003Adolescents.\u2003Guidelines for the Use of Antiretroviral Agents in Adults and Adolescents with HIV.\u2003OARAC\u2003(The\u2003Office\u2003of\u2003AIDS.\u2003Research\u2003Advisory\u2003Council);\u20032021.\u2003Available\u2003at:\u2003https:\/\/www.unaids.org\/sites\/default\/files\/media_asset\/2020_aids-data-book_en.pdf."},{"issue":"1","key":"11395_CR3","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1186\/s12879-020-4837-y","volume":"20","author":"T Zhang","year":"2020","unstructured":"Zhang T, Ding H, An M, Wang X, Tian W, Zhao B, et al. Factors associated with high-risk low-level viremia leading to virologic failure: 16-year retrospective study of a Chinese antiretroviral therapy cohort[J]. BMC Infect Dis. 2020;20(1):147.","journal-title":"BMC Infect Dis"},{"issue":"1","key":"11395_CR4","doi-asserted-by":"publisher","first-page":"3193","DOI":"10.1038\/s41467-019-10884-9","volume":"10","author":"N Bachmann","year":"2019","unstructured":"Bachmann N, von Siebenthal C, Vongrad V, Turk T, Neumann K, Beerenwinkel N, et al. Determinants of HIV-1 reservoir size and long-term dynamics during suppressive ART[J]. Nat Commun. 2019;10(1):3193.","journal-title":"Nat Commun"},{"key":"11395_CR5","doi-asserted-by":"crossref","unstructured":"Siliciano JD, Siliciano RF. Nonsuppressible HIV-1 viremia: a reflection of how the reservoir persists[J]. J Clin Invest 2020,130(11):5665\u20137.","DOI":"10.1172\/JCI141497"},{"issue":"12","key":"11395_CR6","doi-asserted-by":"publisher","first-page":"2145","DOI":"10.1093\/cid\/ciz129","volume":"69","author":"C Joya","year":"2019","unstructured":"Joya C, Won SH, Schofield C, Lalani T, Maves RC, Kronmann K, et al. Persistent Low-level viremia while on antiretroviral therapy is an independent risk factor for virologic Failure[J]. Clin Infect Dis. 2019;69(12):2145\u201352.","journal-title":"Clin Infect Dis"},{"key":"11395_CR7","doi-asserted-by":"publisher","first-page":"1501961833","DOI":"10.1177\/2325958220979817","volume":"19","author":"Z Gaifer","year":"2020","unstructured":"Gaifer Z, Boulassel MR. Low-Level viremia predicts virological failure in HIV-Infected Omani patients receiving antiretroviral Therapy[J]. J Int Assoc Provid AIDS Care. 2020;19:1501961833.","journal-title":"J Int Assoc Provid AIDS Care"},{"issue":"12","key":"11395_CR8","doi-asserted-by":"publisher","first-page":"2079","DOI":"10.1093\/cid\/ciaa413","volume":"72","author":"O Elvstam","year":"2021","unstructured":"Elvstam O, Marrone G, Medstrand P, Treutiger CJ, S\u00f6nnerborg A, Gissl\u00e9n M, et al. All-Cause mortality and serious Non-AIDS events in adults with Low-level human immunodeficiency virus viremia during combination antiretroviral therapy: results from a Swedish nationwide observational Study[J]. Clin Infect Dis. 2021;72(12):2079\u201386.","journal-title":"Clin Infect Dis"},{"issue":"1","key":"11395_CR9","doi-asserted-by":"publisher","first-page":"2919","DOI":"10.1080\/21505594.2021.2004743","volume":"12","author":"C Crespo-Bermejo","year":"2021","unstructured":"Crespo-Bermejo C, de Arellano ER, Lara-Aguilar V, Valle-Millares D, G\u00f3mez-Lus ML, Madrid R, et al. Persistent low-Level viremia in persons living with HIV undertreatment: an unresolved status. Virulence. 2021;12(1):2919\u201331.","journal-title":"Virulence"},{"issue":"7","key":"11395_CR10","doi-asserted-by":"publisher","first-page":"e25550","DOI":"10.1002\/jia2.25550","volume":"23","author":"T Sudjaritruk","year":"2020","unstructured":"Sudjaritruk T, Teeraananchai S, Kariminia A, Lapphra K, Kumarasamy N, Fong MS, et al. Impact of low-level viremia on virological failure among Asian children with perinatally acquired HIV on first-line combination antiretroviral treatment: a multicentre, retrospective cohort study[J]. J Int AIDS Soc. 2020;23(7):e25550.","journal-title":"J Int AIDS Soc"},{"issue":"5","key":"11395_CR11","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1093\/cid\/ciy989","volume":"69","author":"A Esber","year":"2019","unstructured":"Esber A, Polyak C, Kiweewa F, Maswai J, Owuoth J, Maganga L, et al. Persistent Low-level viremia predicts subsequent virologic failure: is it time to change the third 90? Clin Infect Dis. 2019;69(5):805\u201312.","journal-title":"Clin Infect Dis"},{"issue":"1","key":"11395_CR12","doi-asserted-by":"publisher","first-page":"1899","DOI":"10.4102\/ajlm.v11i1.1899","volume":"11","author":"N Nanyeenya","year":"2022","unstructured":"Nanyeenya N, Kiwanuka N, Nakanjako D, Nakigozi G, Kibira SPS, Nabadda S, et al. Low-level viremia: an emerging concern among people living with HIV in Uganda and across sub-Saharan Africa[J]. Afr J Lab Med. 2022;11(1):1899.","journal-title":"Afr J Lab Med"},{"issue":"Suppl 1","key":"11395_CR13","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1111\/hiv.13251","volume":"23","author":"R Bai","year":"2022","unstructured":"Bai R, Lv S, Hua W, Su B, Wang S, Shao Y, et al. Factors associated with human immunodeficiency virus-1 low-level viremia and its impact on virological and immunological outcomes: A retrospective cohort study in beijing, China. HIV Med. 2022;23(Suppl 1):72\u201383.","journal-title":"HIV Med"},{"issue":"1","key":"11395_CR14","doi-asserted-by":"publisher","first-page":"ofu119","DOI":"10.1093\/ofid\/ofu119","volume":"2","author":"C Konstantopoulos","year":"2015","unstructured":"Konstantopoulos C, Ribaudo H, Ragland K, Bangsberg DR, Li JZ. Antiretroviral regimen and suboptimal medication adherence are associated with low-level human immunodeficiency virus viremia. Open Forum Infect Dis. 2015;2(1):ofu119.","journal-title":"Open Forum Infect Dis"},{"issue":"5","key":"11395_CR15","doi-asserted-by":"publisher","first-page":"e0268540","DOI":"10.1371\/journal.pone.0268540","volume":"17","author":"H Brattg\u00e5rd","year":"2022","unstructured":"Brattg\u00e5rd H, Bj\u00f6rkman P, Nowak P, Treutiger CJ, Gissl\u00e9n M, Elvstam O. Factors associated with low-level viremia in people with HIV starting antiretroviral therapy: A Swedish observational study. PLoS ONE. 2022;17(5):e0268540.","journal-title":"PLoS ONE"},{"key":"11395_CR16","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.ijid.2021.02.045","volume":"105","author":"GJ Chen","year":"2021","unstructured":"Chen GJ, Sun HY, Chang SY, Cheng A, Huang YS, Huang SH, et al. Incidence and impact of low-level viremia among people living with HIV who received protease inhibitor- or dolutegravir-based antiretroviral therapy. Int J Infect Dis. 2021;105:147\u201351.","journal-title":"Int J Infect Dis"},{"issue":"4 Suppl 3","key":"11395_CR17","doi-asserted-by":"publisher","first-page":"19667","DOI":"10.7448\/IAS.17.4.19667","volume":"17","author":"G Leierer","year":"2014","unstructured":"Leierer G, Rieger A, Steuer A, Sarcletti M, Geit M, Haas B, et al. Difference in factors associated with low-level viremia and virological failure: results from the Austrian HIV cohort study. J Int AIDS Soc. 2014;17(4 Suppl 3):19667.","journal-title":"J Int AIDS Soc"},{"issue":"4 Suppl 3","key":"11395_CR18","doi-asserted-by":"publisher","first-page":"19828","DOI":"10.7448\/IAS.17.4.19828","volume":"17","author":"F Wiesmann","year":"2014","unstructured":"Wiesmann F, Braun P, Knickmann M, Knechten H. Low level HIV viremia is more frequent under protease-inhibitor containing firstline therapy than under NNRTI-regimens. J Int AIDS Soc. 2014;17(4 Suppl 3):19828.","journal-title":"J Int AIDS Soc"},{"issue":"11","key":"11395_CR19","doi-asserted-by":"publisher","first-page":"e0142923","DOI":"10.1371\/journal.pone.0142923","volume":"10","author":"G Leierer","year":"2015","unstructured":"Leierer G, Grabmeier-Pfistershammer K, Steuer A, Geit M, Sarcletti M, Haas B, et al. Factors associated with Low-Level viremia and virological failure: results from the Austrian HIV cohort study. PLoS ONE. 2015;10(11):e0142923.","journal-title":"PLoS ONE"},{"issue":"4","key":"11395_CR20","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1093\/jac\/dkt484","volume":"69","author":"L Vancoillie","year":"2014","unstructured":"Vancoillie L, Demecheleer E, Callens S, Vogelaers D, Vandekerckhove L, Mortier V, et al. Markers associated with persisting low-level viremia under antiretroviral therapy in HIV-1 infection. J Antimicrob Chemother. 2014;69(4):1098\u2013103.","journal-title":"J Antimicrob Chemother"},{"issue":"12","key":"11395_CR21","doi-asserted-by":"publisher","first-page":"e1815","DOI":"10.1016\/S2214-109X(22)00413-2","volume":"10","author":"HM Chun","year":"2022","unstructured":"Chun HM, Abutu A, Milligan K, Ehoche A, Shiraishi RW, Odafe S, et al. Low-level viremia among people living with HIV in nigeria: a retrospective longitudinal cohort study. Lancet Glob Health. 2022;10(12):e1815\u201324.","journal-title":"Lancet Glob Health"},{"issue":"8","key":"11395_CR22","doi-asserted-by":"publisher","first-page":"2347","DOI":"10.1093\/jac\/dkv099","volume":"70","author":"M Wirden","year":"2015","unstructured":"Wirden M, Todesco E, Valantin MA, Lambert-Niclot S, Simon A, Calin R, et al. Low-level HIV-1 viremia in patients on HAART: risk factors and management in clinical practice. J Antimicrob Chemother. 2015;70(8):2347\u201353.","journal-title":"J Antimicrob Chemother"},{"issue":"2","key":"11395_CR23","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1016\/S1473-3099(17)30681-3","volume":"18","author":"LE Hermans","year":"2018","unstructured":"Hermans LE, Moorhouse M, Carmona S, Grobbee DE, Hofstra LM, Richman DD, et al. Effect of HIV-1 low-level viremia during antiretroviral therapy on treatment outcomes in WHO-guided South African treatment programmes: a multicentre cohort study. Lancet Infect Dis. 2018;18(2):188\u201397.","journal-title":"Lancet Infect Dis"},{"issue":"13","key":"11395_CR24","doi-asserted-by":"publisher","first-page":"2005","DOI":"10.1097\/QAD.0000000000002306","volume":"33","author":"J Fleming","year":"2019","unstructured":"Fleming J, Mathews WC, Rutstein RM, Aberg J, Somboonwit C, Cheever LW, et al. Low-level viremia and virologic failure in persons with HIV infection treated with antiretroviral therapy. AIDS. 2019;33(13):2005\u201312.","journal-title":"AIDS"},{"issue":"5","key":"11395_CR25","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1016\/j.ijantimicag.2019.08.008","volume":"54","author":"LL Yang","year":"2019","unstructured":"Yang LL, Li Q, Zhou LB, Chen SQ. Meta-analysis and systematic review of the efficacy and resistance for human immunodeficiency virus type 1 integrase strand transfer inhibitors. Int J Antimicrob Agents. 2019;54(5):547\u201355.","journal-title":"Int J Antimicrob Agents"},{"issue":"43","key":"11395_CR26","doi-asserted-by":"publisher","first-page":"e13016","DOI":"10.1097\/MD.0000000000013016","volume":"97","author":"K Jacobson","year":"2018","unstructured":"Jacobson K, Ogbuagu O. Integrase inhibitor-based regimens result in more rapid virologic suppression rates among treatment-na\u00efve human immunodeficiency virus-infected patients compared to non-nucleoside and protease inhibitor-based regimens in a real-world clinical setting: A retrospective cohort study. Med (Baltim). 2018;97(43):e13016.","journal-title":"Med (Baltim)"},{"issue":"10","key":"11395_CR27","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1089\/aid.2020.0286","volume":"37","author":"S Mayer","year":"2021","unstructured":"Mayer S, Rayeed N, Novak RM, Li J, Palella FJ, Buchacz K, et al. INSTI-Based initial antiretroviral therapy in adults with HIV, the HIV outpatient study, 2007\u20132018. AIDS Res Hum Retroviruses. 2021;37(10):768\u201375.","journal-title":"AIDS Res Hum Retroviruses"},{"issue":"8","key":"11395_CR28","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1111\/hiv.13265","volume":"23","author":"H \u00c1lvarez","year":"2022","unstructured":"\u00c1lvarez H, Rava M, Mart\u00ednez C, Portilla J, Peraire J, Rivero A, et al. Predictors of low-level HIV viremia and virological failure in the era of integrase inhibitors: A Spanish nationwide cohort. HIV Med. 2022;23(8):825\u201336.","journal-title":"HIV Med"},{"issue":"3","key":"11395_CR29","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1097\/QAD.0000000000000544","volume":"29","author":"MA Vandenhende","year":"2015","unstructured":"Antiretroviral Therapy Cohort Collaboration (ART-CC), Vandenhende MA, Ingle S, May M, Chene G, Zangerle R, et al. Impact of low-level viremia on clinical and virological outcomes in treated HIV-1-infected patients. AIDS. 2015;29(3):373\u201383.","journal-title":"AIDS"},{"issue":"4","key":"11395_CR30","doi-asserted-by":"publisher","first-page":"345","DOI":"10.3851\/IMP3023","volume":"21","author":"J Navarro","year":"2016","unstructured":"Navarro J, Caballero E, Curran A, Burgos J, Oca\u00f1a I, Falc\u00f3 V, et al. Impact of low-level viremia on virological failure in HIV-1-infected patients with stable antiretroviral treatment. Antivir Ther. 2016;21(4):345\u201352.","journal-title":"Antivir Ther"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-11395-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-025-11395-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-11395-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T02:40:00Z","timestamp":1757385600000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-025-11395-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,14]]},"references-count":30,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["11395"],"URL":"https:\/\/doi.org\/10.1186\/s12879-025-11395-3","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,14]]},"assertion":[{"value":"3 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Research and Ethics Committee of Zhongnan Hospital, Wuhan University, P. R. China (2023192\u00a0K), and waiver of consent was included. The study was performed in accordance with the guidelines of the Declaration of Helsinki and relevant regulations.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1024"}}